420 related articles for article (PubMed ID: 27256670)
21. Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke.
Shichinohe H; Kawabori M; Iijima H; Teramoto T; Abumiya T; Nakayama N; Kazumata K; Terasaka S; Arato T; Houkin K
BMC Neurol; 2017 Sep; 17(1):179. PubMed ID: 28886699
[TBL] [Abstract][Full Text] [Related]
22. A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.
Hess DC; Sila CA; Furlan AJ; Wechsler LR; Switzer JA; Mays RW
Int J Stroke; 2014 Apr; 9(3):381-6. PubMed ID: 23692637
[TBL] [Abstract][Full Text] [Related]
23. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study.
Chen CL; Young SH; Gan HH; Singh R; Lao AY; Baroque AC; Chang HM; Hiyadan JH; Chua CL; Advincula JM; Muengtaweepongsa S; Chan BP; de Silva HA; Towanabut S; Suwanwela NC; Poungvarin N; Chankrachang S; Wong KS; Eow GB; Navarro JC; Venketasubramanian N; Lee CF; Bousser MG;
Stroke; 2013 Aug; 44(8):2093-100. PubMed ID: 23780952
[TBL] [Abstract][Full Text] [Related]
24. Safety, Feasibility, and Efficacy of Vagus Nerve Stimulation Paired With Upper-Limb Rehabilitation After Ischemic Stroke.
Dawson J; Pierce D; Dixit A; Kimberley TJ; Robertson M; Tarver B; Hilmi O; McLean J; Forbes K; Kilgard MP; Rennaker RL; Cramer SC; Walters M; Engineer N
Stroke; 2016 Jan; 47(1):143-50. PubMed ID: 26645257
[TBL] [Abstract][Full Text] [Related]
25. Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients.
Taguchi A; Sakai C; Soma T; Kasahara Y; Stern DM; Kajimoto K; Ihara M; Daimon T; Yamahara K; Doi K; Kohara N; Nishimura H; Matsuyama T; Naritomi H; Sakai N; Nagatsuka K
Stem Cells Dev; 2015 Oct; 24(19):2207-18. PubMed ID: 26176265
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092).
Sprigg N; Bath PM; Zhao L; Willmot MR; Gray LJ; Walker MF; Dennis MS; Russell N
Stroke; 2006 Dec; 37(12):2979-83. PubMed ID: 17082474
[TBL] [Abstract][Full Text] [Related]
27. Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture.
Tian C; Wang X; Wang X; Wang L; Wang X; Wu S; Wan Z
Exp Clin Transplant; 2013 Apr; 11(2):176-81. PubMed ID: 22891928
[TBL] [Abstract][Full Text] [Related]
28. Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial.
England TJ; Abaei M; Auer DP; Lowe J; Jones DR; Sare G; Walker M; Bath PM
Stroke; 2012 Feb; 43(2):405-11. PubMed ID: 22198983
[TBL] [Abstract][Full Text] [Related]
29. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
30. CLOTBUST-Hands Free: pilot safety study of a novel operator-independent ultrasound device in patients with acute ischemic stroke.
Barreto AD; Alexandrov AV; Shen L; Sisson A; Bursaw AW; Sahota P; Peng H; Ardjomand-Hessabi M; Pandurengan R; Rahbar MH; Barlinn K; Indupuru H; Gonzales NR; Savitz SI; Grotta JC
Stroke; 2013 Dec; 44(12):3376-81. PubMed ID: 24159060
[TBL] [Abstract][Full Text] [Related]
31. Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury.
Wang S; Cheng H; Dai G; Wang X; Hua R; Liu X; Wang P; Chen G; Yue W; An Y
Brain Res; 2013 Sep; 1532():76-84. PubMed ID: 23942181
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of autologous bone marrow mononuclear cells for cerebral palsy: an open label uncontrolled clinical trial.
Nguyen LT; Nguyen AT; Vu CD; Ngo DV; Bui AV
BMC Pediatr; 2017 Apr; 17(1):104. PubMed ID: 28403842
[TBL] [Abstract][Full Text] [Related]
33. Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery.
Chen S; Liu Z; Tian N; Zhang J; Yei F; Duan B; Zhu Z; Lin S; Kwan TW
J Invasive Cardiol; 2006 Nov; 18(11):552-6. PubMed ID: 17090821
[TBL] [Abstract][Full Text] [Related]
34. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Nuñez-Córdoba JM; Sánchez-Echenique C; Bondía JM; Aquerreta JD; Andreu EJ; Ornilla E; Villarón EM; Valentí-Azcárate A; Sánchez-Guijo F; Del Cañizo MC; Valentí-Nin JR; Prósper F
J Transl Med; 2016 Aug; 14(1):246. PubMed ID: 27565858
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke.
Chung JW; Chang WH; Bang OY; Moon GJ; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH;
Neurology; 2021 Feb; 96(7):e1012-e1023. PubMed ID: 33472925
[TBL] [Abstract][Full Text] [Related]
36. Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial.
Vahidy FS; Haque ME; Rahbar MH; Zhu H; Rowan P; Aisiku IP; Lee DA; Juneja HS; Alderman S; Barreto AD; Suarez JI; Bambhroliya A; Hasan KM; Kassam MR; Aronowski J; Gee A; Cox CS; Grotta JC; Savitz SI
Stem Cells; 2019 Nov; 37(11):1481-1491. PubMed ID: 31529663
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow stromal cell therapy for ischemic stroke: A meta-analysis of randomized control animal trials.
Wu Q; Wang Y; Demaerschalk BM; Ghimire S; Wellik KE; Qu W
Int J Stroke; 2017 Apr; 12(3):273-284. PubMed ID: 27794139
[TBL] [Abstract][Full Text] [Related]
38. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.
Venkataramana NK; Kumar SK; Balaraju S; Radhakrishnan RC; Bansal A; Dixit A; Rao DK; Das M; Jan M; Gupta PK; Totey SM
Transl Res; 2010 Feb; 155(2):62-70. PubMed ID: 20129486
[TBL] [Abstract][Full Text] [Related]
39. White matter lesion severity in mild acute ischemic stroke patients and functional outcome after 1 year.
Leonards CO; Ipsen N; Malzahn U; Fiebach JB; Endres M; Ebinger M
Stroke; 2012 Nov; 43(11):3046-51. PubMed ID: 22935398
[TBL] [Abstract][Full Text] [Related]
40. Impact of General Anesthesia on Safety and Outcomes in the Endovascular Arm of Interventional Management of Stroke (IMS) III Trial.
Abou-Chebl A; Yeatts SD; Yan B; Cockroft K; Goyal M; Jovin T; Khatri P; Meyers P; Spilker J; Sugg R; Wartenberg KE; Tomsick T; Broderick J; Hill MD
Stroke; 2015 Aug; 46(8):2142-8. PubMed ID: 26138125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
